Division of Endocrinology, CSIR-Central Drug Research Institute, Lucknow, 226031, India.
Division of Pharmacology, CSIR-Central Drug Research Institute, Lucknow, 226031, India.
Biomed Pharmacother. 2017 Aug;92:757-771. doi: 10.1016/j.biopha.2017.05.120. Epub 2017 Jun 4.
Atherogenic diet (AD) and high fat diet (HFD) cause deleterious effect on bone micro-architecture and this phenomenon prompts aortic calcification. This study aims to show the effects of Caviunin β-d-glucopyranoside (CAFG), against bone loss and its associated aortic calcification in presence of AD and HFD challenged diets.
Five groups of C57BL/6 male mice with 8 animals in each group, comprising of chow, AD, HFD, AD+CAFG and HFD+CAFG were fed with respective diets for 16 weeks. At the end of the treatment period, preventive effects of CAFG on bone tissue were analyzed by assessing the osteogenic potential of bone marrow cells, bone micro-architecture, ability of new bone formation and histomorphometry studies. Aortic calcification was assessed by transcription and translation analysis of osteogenic key markers in aortic tissue and assessment of aortic endothelial function. Plasma lipid profiling was done to assess the effects of diets as its role in both bone loss and aortic calcification.
Bone marrow stromal cell (BMSC's) dynamics showed that AD and HFD decreased osteoblast number that led to bone loss, deterioration in bone micro-architecture with up-regulated bone resorptive genes that lead to increase in aortic calcification. CAFG treatment rescued the bone health by modulating BMSC's towards osteogenic lineage. It increased the osteogenic gene expression with simultaneous decrease in osteoclastic genes thus stabilized the receptor activator of nuclear factor-kappa-B ligand/osteoprotegerin ratio that eventually reduced the amount of calcification in aorta. Biochemical studies showed that CAFG reduced the TC, TG and LDL-C content with no marked changes in HDL-C. Moreover, CAFG decreased the osteogenic key markers in the aortic tissue and enhanced endothelial function.
Overall, this study indicates that CAFG protected against physiologically challenged diet induced bone loss with associated vascular calcification in mice. Moreover, data revealed that atherogenic diet is more detrimental as compared to the excess fatty acid diet to the bone and aorta.
致动脉粥样硬化饮食(AD)和高脂肪饮食(HFD)对骨微观结构造成有害影响,这种现象促使主动脉钙化。本研究旨在展示 Caviunin β-D-吡喃葡萄糖苷(CAFG)对存在 AD 和 HFD 挑战饮食时的骨丢失及其相关的主动脉钙化的作用。
将 8 只 C57BL/6 雄性小鼠分为 5 组,每组 8 只,分别为普通饮食组、AD 组、HFD 组、AD+CAFG 组和 HFD+CAFG 组,分别喂食相应的饮食 16 周。在治疗期末,通过评估骨髓细胞的成骨潜能、骨微观结构、新骨形成能力和组织形态计量学研究,分析 CAFG 对骨组织的预防作用。通过转录和翻译分析主动脉组织中的成骨关键标志物以及评估主动脉内皮功能来评估主动脉钙化。进行血浆脂质谱分析以评估饮食的作用,因为它在骨丢失和主动脉钙化中都有作用。
骨髓基质细胞(BMSC)动力学表明,AD 和 HFD 减少了成骨细胞数量,导致骨丢失,骨微观结构恶化,破骨基因上调导致主动脉钙化增加。CAFG 治疗通过将 BMSC 向成骨谱系调节来挽救骨骼健康。它增加了成骨基因的表达,同时减少了破骨基因,从而稳定了核因子-κB 配体/骨保护素受体的比率,最终减少了主动脉中的钙化量。生化研究表明,CAFG 降低了 TC、TG 和 LDL-C 的含量,而 HDL-C 没有明显变化。此外,CAFG 降低了主动脉组织中的成骨关键标志物并增强了内皮功能。
总的来说,这项研究表明,CAFG 可预防生理挑战性饮食引起的骨丢失,并伴有小鼠的血管钙化。此外,数据表明,与过量脂肪酸饮食相比,致动脉粥样硬化饮食对骨骼和主动脉的危害更大。